Answers are grounded in this paper and cite their sources.
Background Hereditary fructose intolerance (HFI) is an inborn error of fructose metabolism caused by aldolase B deficiency ( ALDOB ). Patients with HFI require lifelong adherence to a fructose-restricted diet. However, despite strict dietary restriction, both HFI patients and mice with Aldob −/− exhibit hepatocellular accumulation of fructose 1-phosphate (F1P) and intrahepatic lipids (IHL). We studied whether endogenously produced fructose could account for these observations. Methods We first measured serum fructose levels during a 75 g oral glucose tolerance test (OGTT) in patients with HFI ( n = 14) and matched healthy controls ( n = 14). Furthermore, we quantified the incorporation of 13 C 6 -glucose into F1P in Aldob −/− mice ( n = 4) and wildtype mice ( n = 4). Next, we examined the effects of inhibition of endogenous fructose production in Aldob −/ − mice. Aldob −/ − mice were treated for 9 days with an aldose reductase inhibitor (ARi; n = 9) or vehicle ( n = 9) under fructose-free dietary conditions. Results Serum fructose concentrations increased significantly at 30 and 60 min compared to baseline in patients with HFI and controls ( P < 0.05), indicating glucose-derived fructose production. Similar, 13 C 6 -glucose was incorporated into F1P in Aldob −/ − mice and wildtype mice. ARi-treatment significantly reduced hepatic fructose levels in Aldob −/− mice ( P = 0.002), confirming effective inhibition of the polyol pathway, but did not reduce IHL content ( P = 0.71). Conclusions Although endogenous fructose production contributes to circulating and hepatic fructose levels in Aldob −/− , inhibition of the polyol pathway does not reduce hepatic steatosis in Aldob −/ − mice under fructose-free conditions.
No takes yet. Share an insight, caveat, or question.
Buziau et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: